[1]谢玉君.婴幼儿重症肺炎与肺炎高危因素的探讨[J].广州医药,2001,(06):42-43.
[2] Mecklin M, Heikkilä P, Korppi M. Low age, low birthweight and congenital heart disease are risk factors for intensive care in infants with bronchiolitis. ACTA PAEDIATR. 2017;106(12):2004-10.
[3] Le Roux DM, Nicol MP, Vanker A, Nduru PM, Zar HJ. Factors associated with serious outcomes of pneumonia among children in a birth cohort in South Africa. PLOS ONE. 2021;16(8):e255790.
[4] Kasundriya SK, Dhaneria M, Mathur A, Pathak A. Incidence and risk factors for severe pneumonia in children hospitalized with pneumonia in Ujjain, India. International journal of environmental research and public health. 2020;17(13):4637.
[5] Cahyani NRA, Wardani HE, Alma LR. The Relationship Between Human Host and Environmental Factors on the Severity of Pneumonia Among Under-Five Children in West Java Province. Jurnal Ilmu Kesehatan Masyarakat. 2023;14(3):362-80.
[6] Fadl N, Ashour A, Yousry Muhammad Y. Pneumonia among under-five children in Alexandria, Egypt: a case-control study. J EGYPT PUBLIC HEAL. 2020;95(1):14.
[7] Nair NS, Lewis LE, Dhyani VS, et al. Factors associated with neonatal pneumonia and its mortality in India: a systematic review and meta-analysis. INDIAN PEDIATR. 2021;58(11):1059-66.
[8]Srivastava S, Shetty N. Healthcare-associated infections in neonatal units: lessons from contrasting worlds. J HOSP INFECT. 2007;65(4):292-306.
[9] Cione E, Lucente M, Gallelli L, De Sarro G, Luciani F, Caroleo MC. Innate immunity and human milk MicroRNAs content: a new perspective for premature newborns. J Compr Ped. 2017;8(1):e43359.
[10] Crofts KF, Alexander-Miller MA. Challenges for the newborn immune response to respiratory virus infection and vaccination. VACCINES-BASEL. 2020;8(4):558.
[11] Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proceedings of the Royal Society B: Biological Sciences. 2015;282(1821):20143085.
[12]万朝敏李茂霞.婴幼儿重症肺炎的临床特点及死亡相关因素研究[J].中国小儿急救医学.2015;22(2):6.
[13]安丽花,郝瑞影,李晓艳.儿童重症肺炎200例高危因素的临床分析[J].现代医药卫生. 2017;33(5):2.
[14]寇果,陈超辉,张磊.儿童重症肺炎危险因素分析[J].河南医学研究,2024,33(02):334-337.
[15]诸宏伟,刘梅.婴幼儿重症肺炎合并脏器功能衰竭51例分析[J].中华全科医学,2008,(11):1170-1171.
[16]马冬雪,张慧娜,翟英菊,等.营养不良、先天性心脏病与儿童重症肺炎的关联性分析[J].临床肺科杂志,2018,23(05):883-886.
[17]徐雷,陈蕾,王冲,等.儿童重症肺炎105例临床特征及高危因素分析[J].齐鲁医学杂志,2012,27(03):250-252.
[18]Nowrousian MR. Impact of anemia on organ functions. Springer Vienna. 2002.
[19]吕媛,易银沙,李桂南.婴幼儿重症肺炎并发呼吸衰竭高危因素分析[J].中国呼吸与危重监护杂志,2003,(05):42-44.
[20]王战胜. Risk factors of 860 infants with severe pneumonia. Central Plains Medical Journal. 2006;33:20-1.
[21]崔小文.小儿重症腺病毒肺炎混合感染特征及高危因素分析[J] .当代医学. 2017;23(24):3.
[22]唐源.重庆617例甲型流感病毒肺炎患儿临床特征及重症危险因素分析[D].重庆医科大学,2020.
[23]杜芳,黄英,舒畅,尹丽娟,黄亚娜.小儿重症腺病毒肺炎混合感染及高危因素分析[J].中国当代儿科杂志. 2013;15(5):375-8.
[24]阮继锋,温敏宜.小儿重症腺病毒肺炎混合感染特征及高危因素分析[J]. 深圳中西医结合杂志. 2016(010):26.

[25]Qian Y, Zeng Y, Zhang YZ, Chen Y, Nie X. [Risk factors of Pneumocystis carinii pneumonia in childhood-onset systemic lupus erythematosus]. Zhonghua er ke za zhi =Chinese journal of pediatrics. 2022;60 6:608-11.
[26] 周红霞, 赵丽萍, 葛婷婷, 张林, 徐锦雯. 糖皮质激素联合免疫抑制剂治疗小儿肾脏风湿性疾病并发重症肺炎疗效观察[J].现代中西医结合杂志. 2014;23(20):3.
[27]Gjeta I, Sala D, Kola IBC. Surfactant Deficiency Causing Severe Pneumonia in a Child. Current Health Sciences Journal. 2023;49(1):134-8.
[28] 杨晓丹. 小儿重症肺炎的临床诊断与治疗[J].中国医药指南. 2016;14(13):1.
[29] 蒋伟燕, 李航逸, 瞿晓晓, 李绵绵, 赖媚媚, 余玲玲. 中性粒细胞/淋巴细胞比值在儿童重症肺炎中的诊断价值[J]. 中国卫生检验杂志. 2022(011):32.
[30] 刘昊旻. 中性粒细胞与淋巴细胞比值（NLR）对儿童重症肺炎严重程度及预后的评估作用[D]. 川北医学院,2021.
[31] 江丽. 中性粒细胞与淋巴细胞比值, 血小板与淋巴细胞比值和红细胞分布宽度评估重症肺炎患儿预后的临床价值[J].山西卫生健康职业学院学报. 2022(001):32.
[32] 苏国德, 彭效芹, 毕颖, 屈昌雪, 张振坤. 中性粒细胞与淋巴细胞比值在儿童难治性肺炎支原体肺炎中的诊断及预测价值[J].徐州医科大学学报. 2022.
[33] Salzano G, Barone S, Luca PD, et al. Predictive value of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic inflammatory index for detection of recurrence of pleomorphic adenoma of the major salivary glands: a multicenter study. Oral surgery, oral medicine, oral pathology and oral radiology.:S2212-4403.
[34] Chiheri DM, Sasaran MO, Melit LE. Role of mean platelet volume and platelet/ lymphocyte ratio in assessing the severity of acute respiratory infections in children. Romanian Journal of Pediatrics. 2020(2).
[35] Ling Y, Ning J, Xu Y. Explore the Predictive Value of Peripheral Blood Cell Parameters in Refractory Mycoplasma pneumoniae Pneumonia in Children Over 6 Years Old.FRONT PEDIATR. 2021.
[36] Wu J, Wang X, Zhou M, et al. The value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in differentiating pneumonia from upper respiratory tract infection (URTI) in children: a cross-sectional study. BMC PEDIATR. 2021;21(1):545.
[37] 陈浩俊, 祝绚, 李红, 刘成桂. 单核淋巴细胞比值和红细胞分布宽度在儿童社区获得性肺炎中的临床价值[J].微循环学杂志. 2020;30(3):5.
[38]黎小梅,夏宏,郑应莲,毛国其.外周血纤维蛋白降解产物,单核细胞/淋巴细胞比值[J].中性粒细胞/淋巴细胞比值对重症肺炎患儿预后的评估价值[J].儿科药学杂志.2021;27(2):5.
[39] 孙亨秋. CRP 与白蛋白比值在婴幼儿重症肺炎病情及预后评估中的价值[J].温州医科大学学报. 2018;48(03):220-4.
[40]陈瑞芳,周信英,何国芳,王少华. C-反应蛋白/白蛋白与儿童支原体性肺炎严重程度相关性分析[J].中国妇幼保健; Maternal & Child Health Care of China. 2023;38 (9):1621-4.
[41] 刘娴. 儿童重症腺病毒肺炎临床特征及CRP/ALB比值与患儿预后的关系[D]. 吉首大学,2021.
[42] 苗芝育, 张磊, 李晓燕, 等. 乳酸/白蛋白比值、白细胞介素-6、CD4+T淋巴细胞计数对重症肺炎并脓毒症患者短期预后的预测价值[J].新乡医学院学报,2024,41(03):232-239.
[43] 马娜, 金雨舟, 刘福菁, 沈婉林, 顾体军. 乳酸脱氢酶白蛋白比值对重症肺炎患者并发弥散性血管内凝血的预测价值[J].中国呼吸与危重监护杂志. 2023;22(12):845-51.